| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 528 | 2020 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 386 | 2017 |
| Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts I Motta, R Centis, L D’Ambrosio, JM García-García, D Goletti, G Gualano, ... Pulmonology 26 (4), 233-240, 2020 | 269 | 2020 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 246 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 241 | 2020 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 202 | 2019 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study GB Migliori, PM Thong, JW Alffenaar, J Denholm, M Tadolini, F Alyaquobi, ... European Respiratory Journal 58 (5), 2021 | 173 | 2021 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 154 | 2022 |
| A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients L Petrone, E Petruccioli, V Vanini, G Cuzzi, SN Fard, T Alonzi, C Castilletti, ... Clinical microbiology and infection 27 (2), 286. e7-286. e13, 2021 | 144 | 2021 |
| IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis E Petruccioli, L Petrone, V Vanini, A Sampaolesi, G Gualano, E Girardi, ... Journal of Infection 66 (6), 475-486, 2013 | 139 | 2013 |
| Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB S Tiberi, MC Payen, G Sotgiu, L D'Ambrosio, VA Guizado, JW Alffenaar, ... European Respiratory Journal 47 (4), 1235-1243, 2016 | 125 | 2016 |
| Multidrug-resistant tuberculosis in Europe, 2010–2011 G Guenther, F Van Leth, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... Emerging infectious diseases 21 (3), 409, 2015 | 116 | 2015 |
| ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update GB Migliori, G Sotgiu, S Rosales-Klintz, R Centis, L D'Ambrosio, ... European Respiratory Journal 51 (5), 2018 | 104 | 2018 |
| Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2 L Petrone, E Petruccioli, V Vanini, G Cuzzi, G Gualano, P Vittozzi, ... International journal of infectious diseases 113, S82-S87, 2021 | 99 | 2021 |
| Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB S Tiberi, G Sotgiu, L D'Ambrosio, R Centis, MA Arbex, EA Arrascue, ... European Respiratory Journal 47 (6), 1758-1766, 2016 | 99 | 2016 |
| Treatment outcomes in multidrug-resistant tuberculosis G Guenther, C Lange, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... New England Journal of Medicine 375 (11), 1103-1105, 2016 | 98 | 2016 |
| Increase in tuberculosis diagnostic delay during first wave of the COVID-19 pandemic: data from an Italian infectious disease referral hospital F Di Gennaro, G Gualano, L Timelli, P Vittozzi, V Di Bari, R Libertone, ... Antibiotics 10 (3), 272, 2021 | 94 | 2021 |
| New antituberculosis drugs: from clinical trial to programmatic use G Gualano, S Capone, A Matteelli, F Palmieri Infectious disease reports 8 (2), 2016 | 94 | 2016 |
| Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis G Sotgiu, S Tiberi, L D'Ambrosio, R Centis, JW Alffenaar, JA Caminero, ... European Respiratory Journal 48 (5), 1503-1507, 2016 | 89 | 2016 |
| Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non–small-cell lung cancer L Trodella, P Granone, S Valente, A Turriziani, G Macis, GM Corbo, ... Journal of clinical oncology 20 (3), 804-810, 2002 | 88 | 2002 |
